The "Psychosocial Aspects in Hereditary Cancer" questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French-, German- and Spanish-language versions.
Adolescent
Adult
Aged
Aged, 80 and over
Breast Neoplasms
/ genetics
Factor Analysis, Statistical
Female
France
Genetic Counseling
/ psychology
Genetic Predisposition to Disease
/ psychology
Genetic Testing
Germany
Hereditary Breast and Ovarian Cancer Syndrome
/ psychology
Humans
Middle Aged
Minimal Clinically Important Difference
Needs Assessment
Psychological Distress
Psychometrics
Reproducibility of Results
Spain
Surveys and Questionnaires
Translations
Young Adult
breast cancer
cross-cultural
genetics
minimal important difference
psychometrics
Journal
European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
13
12
2018
revised:
23
05
2019
accepted:
04
09
2019
pubmed:
2
10
2019
medline:
18
11
2020
entrez:
2
10
2019
Statut:
ppublish
Résumé
We performed a comprehensive assessment of the psychometrics of the "Psychosocial Aspects in Hereditary Cancer" (PAHC) questionnaire in French, German and Spanish. Women consecutively approached in Cancer Genetic Clinics completed the PAHC, distress and satisfaction questionnaires at pre-testing (T1) and after test result disclosure (T2). In addition to standard psychometric attributes, we assessed the PAHC ability to respond to change (i.e. improvement or deterioration from T1 to T2) in perceived difficulties and computed minimal important differences (MID) in PAHC scores as compared with self-reported needs for additional counselling. Of 738 eligible counselees, 214 (90%) in France (Paris), 301 (92%) in Germany (Cologne) and 133 (77%) in Spain (Barcelona) completed the PAHC. A six-factor revised PAHC model yielded acceptable CFA goodness-of-fit indexes and good all scales internal consistencies. PAHC scales demonstrated expected conceptual differences with distress and satisfaction with counselling. Different levels of psychosocial difficulties were evidenced between counselees' subgroups and over time (p-values < .05). MID estimates ranged from 8 to 15 for improvement and 9 to 21 for deterioration. The PAHC French, German and Spanish versions are reliable and valid for evaluating the psychosocial difficulties of women at high BC risk attending genetic clinics.
Sections du résumé
BACKGROUND
BACKGROUND
We performed a comprehensive assessment of the psychometrics of the "Psychosocial Aspects in Hereditary Cancer" (PAHC) questionnaire in French, German and Spanish.
METHODS
METHODS
Women consecutively approached in Cancer Genetic Clinics completed the PAHC, distress and satisfaction questionnaires at pre-testing (T1) and after test result disclosure (T2). In addition to standard psychometric attributes, we assessed the PAHC ability to respond to change (i.e. improvement or deterioration from T1 to T2) in perceived difficulties and computed minimal important differences (MID) in PAHC scores as compared with self-reported needs for additional counselling.
RESULTS
RESULTS
Of 738 eligible counselees, 214 (90%) in France (Paris), 301 (92%) in Germany (Cologne) and 133 (77%) in Spain (Barcelona) completed the PAHC. A six-factor revised PAHC model yielded acceptable CFA goodness-of-fit indexes and good all scales internal consistencies. PAHC scales demonstrated expected conceptual differences with distress and satisfaction with counselling. Different levels of psychosocial difficulties were evidenced between counselees' subgroups and over time (p-values < .05). MID estimates ranged from 8 to 15 for improvement and 9 to 21 for deterioration.
CONCLUSION
CONCLUSIONS
The PAHC French, German and Spanish versions are reliable and valid for evaluating the psychosocial difficulties of women at high BC risk attending genetic clinics.
Types de publication
Journal Article
Validation Study
Langues
eng
Pagination
e13173Subventions
Organisme : European Union Horizon 2020
ID : 634935
Informations de copyright
© 2019 John Wiley & Sons Ltd.
Références
Albada, A., van Dulmen, S., Lindhout, D., Bensing, J. M., & Ausems, M. G. (2012). A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling. Familial Cancer, 11(1), 85-95. https://doi.org/10.1007/s10689-011-9479-1
Baguena, M. J., Villaroya, E., Belena, A., Díaz, A., Roldán, C., & Reig, R. (2001). Psychometric properties of the Spanish version of the Impact of Event Scale-Revised (IES-R). Analisis y. Modificacion De Conducta, 27, 581-604. https://www.uv.es/baguena/art-IES-R.pdf
Bennett, P., Phelps, C., Hilgart, J., Hood, K., Brain, K., & Murray, A. (2012). Concerns and coping during cancer genetic risk assessment. Psycho-Oncology, 21(6), 611-617. https://doi.org/10.1002/pon.1938
Bradbury, A. R., Patrick-Miller, L. J., Egleston, B. L., Hall, M. J., Domchek, S. M., Daly, M. B., … Yao, X. S. (2018). Randomized noninferiority trial of telephone vs in-person disclosure of germline cancer genetic test results. Journal of the National Cancer Institute, 110(9), 985-993. https://doi.org/10.1093/jnci/djy015
Bredart, A., Kop, J.-L., Griesser, A.-C., Fiszer, C., Zaman, K., Panes-Ruedin, B., … Dolbeault, S. (2013). Assessment of needs, health-related quality of life, and satisfaction with care in breast cancer patients to better target supportive care. Annals of Oncology, 24(8), 2151-2158. https://doi.org/10.1093/annonc/mdt128
Brunet, A., St-Hilaire, A., Jehel, L., & King, S. (2003). Validation of a French version of the impact of event scale-revised. Canadian Journal of Psychiatry, 48(1), 56-61. https://doi.org/10.1177/070674370304800111
Cella, D., Hughes, C., Peterman, A., Chang, C.-H., Peshkin, B. N., Schwartz, M. D., … Lerman, C. (2002). A brief assessment of concerns associated with genetic testing for cancer: The multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychology, 21(6), 564-572. https://doi.org/10.1037/0278-6133.21.6.564
Cohen, J. (1988). Statistical power analysis for the behavioural sciences (2nd edn). New Jersey: Lawrence Earlbaum.
Couch, F. J., Nathanson, K. L., & Offit, K. (2014). Two decades after BRCA: Setting paradigms in personalized cancer care and prevention. Science, 343(6178), 1466-1470. https://doi.org/10.1126/science.1251827
Cronbach, L. J., & Warrington, W. G. (1951). Time-limit tests: Estimating their reliability and degree of speeding. Psychometrika, 16(2), 167-188. https://doi.org/10.1007/BF02289113
Dewolf, L., Koller, M., Velikova, G., Johnson, C., Scott, N., & Bottomley, A. (2009). EORTC quality of life group translation procedure. Brussels: EORTC Quality of Life Group.
Domchek, S. M., Bradbury, A., Garber, J. E., Offit, K., & Robson, M. E. (2013). Multiplex genetic testing for cancer susceptibility: Out on the high wire without a net? Journal of Clinical Oncology, 31(10), 1267-1270. JCO.2012.46.9403 [pii]
Eijzenga, W., Aaronson, N. K., Hahn, D. E. E., Sidharta, G. N., van der Kolk, L. E., Velthuizen, M. E., … Bleiker, E. M. A. (2014). Effect of routine assessment of specific psychosocial problems on personalized communication, Counselors' awareness, and distress levels in cancer genetic counseling practice: A randomized controlled trial. Journal of Clinical Oncology, 2(27), 2998-3004. https://doi.org/10.1200/JCO.2014.55.4576
Eijzenga, W., Bleiker, E. M., Hahn, D. E., Kluijt, I., Sidharta, G. N., Gundy, C., & Aaronson, N. K. (2014). Psychosocial Aspects of Hereditary Cancer (PAHC) questionnaire: Development and testing of a screening questionnaire for use in clinical cancer genetics. Psycho-Oncology, 23(8), 862-869. https://doi.org/10.1002/pon.3485
Eijzenga, W., Bleiker, E. M., Hahn, D. E., Van der Kolk, L. E., Sidharta, G. N., & Aaronson, N. K. (2015). Prevalence and detection of psychosocial problems in cancer genetic counseling. Familial Cancer, 14(4), 629-636. https://doi.org/10.1007/s10689-015-9809-9
Esteban, I., Vilaró, M., Adrover, E., Angulo, A., Carrasco, E., Gadea, N., … Balmaña, J. (2018). Psychological impact of multi-gene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain. Psycho-Oncology, 27(6), 1530-1537. https://doi.org/10.1002/pon.4686
Fayers, P. M., & Machin, D. (2000). "Missing Data.", chap 11. In P. M. Fayers & D. Machin (Eds.), Quality of life: assessment, analysis and interpretation (pp. 224-247). Chichester: John Wiley & Sons.
Farrelly, A., White, V., Meiser, B., Jefford, M., Young, M.-A., Ieropoli, S., … Duffy, J. (2013). Unmet support needs and distress among women with a BRCA1/2 mutation. Familial Cancer, 12(3), 509-518. https://doi.org/10.1007/s10689-012-9596-5
Hamilton, J. G., Lobel, M., & Moyer, A. (2009). Emotional distress following genetic testing for hereditary breast and ovarian cancer: A meta-analytic review. Health Psychology, 28(4), 510-518. https://doi.org/10.1037/a0014778
Herrero, M. J., Blanch, J., Peri, J. M., De Pablo, J., Pintor, L., & Bulbena, A. (2003). A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. General Hospital Psychiatry, 25(4), 277-283. https://doi.org/10.1016/S0163-8343(03)00043-4
Hiraki, S., Rinella, E. S., Schnabel, F., Oratz, R., & Ostrer, H. (2014). Cancer risk assessment using genetic panel testing: Considerations for clinical application. J Genet Couns, 23(4), 604-617. https://doi.org/10.1007/s10897-014-9695-6
Jackson, D. L., Gillaspy, J. A., & Purc-Stephenson, R. (2009). Reporting practices in confirmatory factor analysis: An overview and some recommendations. Psychological Methods, 14(1), 6-23. https://doi.org/10.1037/a0014694
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10(4), 407-415. https://doi.org/10.1016/0197-2456(89)90005-6
Johnson, C., Blazeby, J. M., Bottomley, A., Fayers, P., Koller, K., Kuliś, D., & Ramage, J., Sprangers, M., Velikova, G., Young, T. & on behalf of the EORTC Quality of Life Group (2011). EORTC Quality of Life Group Guidelines for developing questionnaire modules. Bruxelles: EORTC Quality of Life Group.
Kuliś, D., Bottomley, A., Velikova, G., Greimel, E., Koller, M. & on behalf of the EORTC Quality of Life Group (2017). EORTC Quality of Life Group Translation procedure. Bruxelles: EORTC Quality of Life Group.
Lumish, H. S., Steinfeld, H., Koval, C., Russo, D., Levinson, E., Wynn, J., … Chung, W. K. (2017). Impact of panel gene testing for hereditary breast and ovarian cancer on patients. Journal of Genetic Counseling, 26(5), 1116-1129. https://doi.org/10.1007/s10897-017-0090-y
Maringwa, J., Quinten, C., King, M., Ringash, J., Osoba, D., Coens, C., … Bottomley, A. (2011). Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Annals of Oncology, 22(9), 2107-2112. https://doi.org/10.1093/annonc/mdq726
Mokkink, L. B., Terwee, C., Patrick, D. L., Alonso, J., Stratford, P. W., Knowl, D. L., Bouter, L. M., & de Vet, H. C. W.Cosmin checklist manual, February 2010, VU University Medical Center, Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, Amsterdam, The Netherlands (www.cosmin.nl).
Oberguggenberger, A., Sztankay, M., Morscher, R. J., Sperner-Unterweger, B., Weber, I., Hubalek, M., … Meraner, V. (2016). Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study. Journal of Psychosomatic Research, 89, 39-45. https://doi.org/10.1016/j.jpsychores.2016.08.005
Pieterse, A. H., Ausems, M. G., Van Dulmen, A. M., Beemer, F. A., & Bensing, J. M. (2005). Initial cancer genetic counseling consultation: Change in counselees' cognitions and anxiety, and association with addressing their needs and preferences. American Journal of Medical Genetics. Part A, 137(1), 27-35. https://doi.org/10.1002/ajmg.a.30839
Pieterse, A. H., van Dulmen, A. M., Beemer, F. A., Bensing, J. M., & Ausems, M. G. (2007). Cancer genetic counseling: Communication and counselees' post-visit satisfaction, cognitions, anxiety, and needs fulfillment. Journal of Genetic Counseling, 16(1), 85-96. https://doi.org/10.1007/s10897-006-9048-1
Razavi, D., Delvaux, N., Farvacques, C., & Robaye, E. (1990). Screening for adjustment disorders and major depressive disorders in cancer in-patients. British Journal of Psychiatry, 156, 79-83. https://doi.org/10.1192/bjp.156.1.79
Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61, 102-109. https://doi.org/10.1016/j.jclinepi.2007.03.012
Sun, K. S., Lam, T. P., Lam, K. F., Lo, T. L., Chao, D. V. K., & Lam, E. W. W. (2018). Enablers to seeking professional help for psychological distress-a study on Chinese primary care attenders. Psychiatry Research, 264, 9-14. https://doi.org/10.1016/j.psychres.2018.03.056
Taylor, A., Brady, A. F., Frayling, I. M., Hanson, H., Tischkowitz, M., Turnbull, C. … Guidelines of the UK Cancer Genetics Group (2018). Consensus for genes to be included on cancer panel tests offered by UK genetics services: Guidelines of the UK Cancer Genetics Group. Journal of Medical Genetics, 55(6), 372-377. https://doi.org/10.1136/jmedgenet-2017-105188
van Roosmalen, M. S., Stalmeier, P. F. M., Verhoef, L. C. G., Hoekstra-Weebers, J. E. H. M., Oosterwijk, J. C., Hoogerbrugge, N., … van Daal, W. A. J. (2004). Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. British Journal of Cancer, 90(2), 333-342. https://doi.org/10.1038/sj.bjc.6601525
Weiss, D. S., & Marmar, C. R. (1997). The impact of event scale - revised. In J. P. Wilson, & T. M. Keane (Eds.), Assessing psychological trauma and PTSD (pp. 399-411). New York: Guilford Press.